Women's Health

Interventions have been implemented to raise the number of applications to OBGYN programs, including allowing applicants to submit up to 18 signals relating to their preferred programs.

Cortisol is a stress regulating hormone with associated adverse health outcomes for prolonged exposure including diabetes and high blood pressure.

Despite previously suggested benchmarks, investigators found that spending less time-in-range (TIR) can still improve maternal and perinatal outcomes among pregnant patients with type 1 diabetes (T1D).

Investigators noted that findings data should inform public health policy and reassure providers and expectant mothers.

The Affordable Care Act mandates that contraceptives must be covered by health plans and insurers without cost-sharing.

Findings from the current study lend scientific credence to the idea that making informed dietary choices can help promote favorable health outcomes.

Results from a meta-analysis demonstrated that magnesium supplementation was able to decrease fasting glucose levels and improve insulin resistance.

Women with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.

A new report from the CDC demonstrated a decrease in cigarette smoking across all race and ethnic groups from 2016 to 2022, illustrating a promising trend with potential public health benefits.

Lupin gained FDA approval for varenicline tablets (0.5 mg and 1 mg) and launched its already-approved Turqoz (norgestrel and ethinyl estradiol) tablets USP, 0.3 mg/0.03 mg earlier this month.

Immunizations against influenza, COVID-19, and RSV are lower than they were this time last year, and hospitalizations have increased across all age groups.

The mediterranean diet targets inflammation, oxidative stress, and hormonal balance mechanisms, which are also associated with female reproductive outcomes.

A recent study found that cannabis exposure over the course a pregnancy was associated with small-for-gestational-age birth, medically indicated preterm birth, stillbirth, or hypertensive disorders of pregnancy.

Study results highlight the potential of blood-based markers in understanding neurological conditions.

A Q&A with Kevin Malloy, PharmD, BCPS, on how diabetes technology has improved and how it can help pregnant people manage their disease.

A poster presented at ASHP Midyear 2023 highlighted the positive impact of including pharmacists in the care of postpartum women at risk of persistently elevated blood pressure (BP), particularly in cases of portopulmonary hypertension (PPHTN).

A poster from ASHP Midyear 2023 demonstrated the effectiveness of liposomal bupivacaine as it is used for cesarean section procedures, regarded as an area with increasing utilization.

The risks of poor health, more health care needs, and gynecological cancer are significantly increased in patients with disabilities.

A Q&A with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, director of education and training in diabetes technology at the Cleveland Clinic.

Study findings offer critical insight into the development of sex-specific treatment and prevention strategies for Alzheimer’s disease.

Reproductive-aged women who consume energy drinks should be aware of the potential risks, as energy drink consumption has been linked to adverse pregnancy outcomes.